OpenVSafe by OpenVAERS
Search V-safe

A72-58968-94354

4 vaccinations 7 coded responses 13 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
852 / AZ
Registered
2021-03-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-13
    Registered in v-safe
  2. 2021-03-13
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-13
    Health check-in — day 0, dose 1
    Feeling: Good · Headache, Muscle or body aches
    Adult check-in
  4. 2021-03-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Chills
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-03
    Dose 2 — Pfizer-BioNTech
  7. 2021-04-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Bradykinesia, Fatigue, Malaise — Feeling: Good · Site: Pain
    Free text: A sinking feeling but not fatigue. Like I was severely slowing down.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches
    Adult check-in
  9. 2021-04-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-07-03
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-10-02
    Survey response — 6 months, dose 2
    MedDRA: Office visit, Rash, Skin burning sensation, Skin exfoliation — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Neck rash that burns and the peels and reoccurs every 2-3 weeks. This started eight weeks after my second shot. · Healthcare visit (other): 2 dermatologists and three doctors
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-10-02
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  13. 2021-10-08
  14. 2021-10-11
  15. 2021-12-22
    Dose 3 — Pfizer-BioNTech
  16. 2021-12-23
    Survey response — days 1–6 daily, dose 3
    MedDRA: Office visit, Rash, Rash erythematous, Rash pruritic, Skin exfoliation, Skin warm, Telemedicine — Feeling: Good · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): Dermatologist has prescribed eConozole for a persistent neck rash, starting 3 months after the first shot, that is itchy, hot, bright red and peels. The medication keeps the rash somewhat contained to the neck and upper chest area. · Healthcare visit (other): Dermatologist and Telehealth.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-12-23
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-12-27
    Call successful
    Participant prefers to complete VAERS report online
  19. 2021-12-27
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  20. 2022-02-02
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  21. 2022-03-23
    Survey response — 3 months, dose 3
    MedDRA: Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Persistent rash on next, reoccurring rash on face
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-03-23
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-03-24
  24. 2022-04-27
    Dose 4 — Pfizer-BioNTech
  25. 2022-05-02
    Survey response — days 1–6 daily, dose 4
    MedDRA: Office visit — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional
    Free text: Dermatologist
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-05-02
    Report sent to call center — days 1–6 daily, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2022-05-03
  28. 2023-04-27
    Survey response — 12 months, dose 4
    MedDRA: Office visit, Rash — Feeling: Poor · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  29. 2023-04-27
    Report sent to call center — 12 months, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2023-04-28
  31. 2023-04-28
  32. 2023-04-28

Vaccinations

DoseDateManufacturerCo-administered
12021-03-13Pfizer-BioNTech
22021-04-03Pfizer-BioNTech
32021-12-22Pfizer-BioNTech No
42022-04-27Pfizer-BioNTech No

Call center

5 call center cases

2 successful · 3 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-14

Systemic reaction (other): None

Release 6 — days 1–6 daily, dose 2

2021-04-05

Systemic reaction (other): A sinking feeling but not fatigue. Like I was severely slowing down.

Release 9 — 6 months, dose 2

2021-10-02

Symptoms: Neck rash that burns and the peels and reoccurs every 2-3 weeks. This started eight weeks after my second shot.
Healthcare visit (other): 2 dermatologists and three doctors

Release 10 — days 1–6 daily, dose 3

2021-12-23

Systemic reaction (other): Dermatologist has prescribed eConozole for a persistent neck rash, starting 3 months after the first shot, that is itchy, hot, bright red and peels. The medication keeps the rash somewhat contained to the neck and upper chest area.
Healthcare visit (other): Dermatologist and Telehealth.

Release 11 — 3 months, dose 3

2022-03-23

Symptoms: Persistent rash on next, reoccurring rash on face

Release 11 — days 1–6 daily, dose 4

2022-05-02

Healthcare visit (other): Dermatologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOTelemedicine · · ✓
SDRash · · ✓
SDSkin burning sensation · · ✓
SDSkin exfoliation · · ✓
SROBradykinesia · · ✓
SROFatigue ✓ ✓ ○
SROMalaise ✓ ✓ ○
SRONo adverse event ✓ ✓ ✓
SRORash · · ✓
SRORash erythematous · · ✓
SRORash pruritic · · ✓
SROSkin exfoliation · · ✓
SROSkin warm · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release